Kristen Fortney, CEO of BioAge Labs, on AI Aging Research

Artificial Intelligence in Drug Discovery - A podcast by Simon Smith

Categories:

On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the diseases for which aging puts people at greater risk. In this episode, you’ll learn how BioAge combines unique data sources with in silico analysis and lab experimentation to expedite the search for novel interventions that might just help you live healthier, longer. This episode is brought to you by BenchSci ( www.benchsci.com ). BenchSci uses artificial intelligence to reduce the cost of scientific experiments. Use it to find research antibodies up to 24x faster than using PubMed or Google Scholar. Just enter a protein of interest and filter by technique, organism, tissue, or several other options. BenchSci returns only relevant published figures and products. It’s free for academic researchers. Learn more and sign up at www.benchsci.com .